Sort
82,697 grants matching “vaccine development”
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,812,281Jacques F Banchereau · Baylor Research Institute · U19 · FY2010 · AI
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$4,810,822Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2020 · CA
Exploring novel nucleic acid therapeutic delivery methods and therapeutic strategies
$4,810,759Peter Sarnow · Stanford University · U19 · FY2022 · AI
SDMC: HIV Prevention Trials Network
$4,802,446Deborah J Donnell · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
External Quality Assurance Program Oversight Laboratory (EQAPOL)
$4,800,982Thomas Denny · Duke University · N01 · FY2021 · AI
Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community
$4,798,286Rebecca Bradford · American Type Culture Collection · C06 · FY2023 · OD
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
$4,797,577Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2025 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$4,795,200Jeffrey Lennox · Emory University · UM1 · FY2020 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,794,780Kevin O Saunders · Duke University · U19 · FY2024 · AI
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA
$4,794,576Rolando Herrero · Fundacion Inciensa · N01 · FY2010 · CA
Soweto Clinical Trials Unit
$4,791,396James Alasdair McIntyre · Wits Health Consortium (Pty), Ltd · U01 · FY2009 · AI
Human monoclonal antibodies for hantaviruses
$4,790,125James E Crowe · Vanderbilt University Medical Center · U19 · FY2024 · AI
Collaboratory of AIDS Researchers for Eradication (CARE)
$4,789,982David M. Margolis · Univ Of North Carolina Chapel Hill · UM1 · FY2019 · AI
Center for AIDS Research
$4,784,154David Mitchell Smith · University Of California, San Diego · P30 · FY2021 · AI
GENERAL CLINICAL RESEARCH CENTER
$4,783,061New York University School Of Medicine · M01 · FY2003 · RR
Project 2: Vaccine Design Epidemic Flaviviruses
$4,782,234Aravinda M De Silva · Washington University · U19 · FY2024 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$4,779,318Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2011 · AI
Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity (IMPACT-CETR)
$4,776,780Richard Malley · Boston Children'S Hospital · U19 · FY2025 · AI
PREMISE: Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology
$4,771,281Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
$4,770,702Andrew B Norman · University Of Cincinnati · U01 · FY2019 · DA
IP16-003, Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$4,770,431Cheryl Cohen · National Health Laboratory Service · U01 · FY2020 · IP
PREMISE: Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology
$4,766,197Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Advancement of Vaccines and Therapies for Henipaviruses
$4,765,823Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2021 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,764,161Yong-Jun Liu · Baylor Research Institute · U19 · FY2011 · AI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
$4,758,033Constance Ann Benson · University Of California, San Diego · U01 · FY2009 · AI